We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$280M
AUM Growth
+$20.1M
Cap. Flow
-$12.5M
Cap. Flow %
-4.46%
Top 10 Hldgs %
29.94%
Holding
74
New
13
Increased
17
Reduced
27
Closed
12

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.85M
2
AET
Aetna Inc
AET
+$6.84M
3
UHS icon
Universal Health Services
UHS
+$6.75M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.97M
5
CAH icon
Cardinal Health
CAH
+$3.07M

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$4.68M
2
ESRX
Express Scripts Holding Company
ESRX
+$3.86M
3
COR icon
Cencora
COR
+$3.68M
4
SYK icon
Stryker
SYK
+$3.41M
5
MOH icon
Molina Healthcare
MOH
+$3.19M

Sector Composition

Rank Sector Weight
1 Healthcare 91.22%
2 Financials 2.53%
3 Energy 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMS icon
51
Fresenius Medical Care
FMS
$12.6B
$2.06M 0.73%
40,000
+5,000
+14% +$250K
ENDP
52
DELISTED
Endo International plc
ENDP
$2.02M 0.72%
120,000
-60,000
-33% -$852K
AKRX
53
DELISTED
Akorn Inc
AKRX
$1.82M 0.65%
140,000
+40,000
+40% +$657K
CHRS icon
54
Coherus Oncology
CHRS
$190M
$1.64M 0.58%
99,101
-899
-0.9% -$15.9K
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2B
$1.54M 0.55%
20,000
-5,000
-20% -$402K
SAGE
56
DELISTED
Sage Therapeutics
SAGE
$1.41M 0.5%
10,000
-15,000
-60% -$2.32M
BLUE
57
DELISTED
bluebird bio
BLUE
$1.09M 0.39%
579
-1,351
-70% -$2.79M
A icon
58
Agilent Technologies
A
$41.8B
$1.06M 0.38%
15,000
-45,000
-75% -$2.98M
PTLA
59
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$874K 0.31%
32,802
+17,802
+119% +$581K
SEM
60
DELISTED
Select Medical
SEM
$552K 0.2%
+55,680
New +$576K
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$5.07B
– –
-47,351
Closed -$723K
CRSP icon
62
CRISPR Therapeutics
CRSP
$5.21B
– –
-35,000
Closed -$2.06M
NVO
63
Novo Nordisk
NVO
$202B
– –
-100,000
Closed -$2.31M
PBYI icon
64
Puma Biotechnology
PBYI
$458M
– –
-20,000
Closed -$1.18M
RDY icon
65
Dr. Reddy's Laboratories
RDY
$10.3B
– –
-450,000
Closed -$2.9M
ZTS icon
66
Zoetis
ZTS
$30B
– –
-55,000
Closed -$4.68M
NVRO
67
DELISTED
NEVRO CORP.
NVRO
– –
-16,002
Closed -$1M
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-55,000
Closed -$2.5M
XENT
69
DELISTED
Intersect ENT, Inc
XENT
– –
-43,000
Closed -$1.61M
ONCE
70
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-20,000
Closed -$1.66M
TSRO
71
DELISTED
TESARO, Inc.
TSRO
– –
-60,000
Closed -$2.67M
ESRX
72
DELISTED
Express Scripts Holding Company
ESRX
– –
-50,000
Closed -$3.86M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q3 2018 Portfolio in Review

As of Q3 2018, Sivik Global Healthcare held 74 positions worth $280M, up 7.7% from $260M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare withdrew a net $12.5M in Q3 2018, closing 12 positions and reducing 27 holdings. Its most notable exit was Zoetis, an estimated $4.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.65M.

  • Sivik Global Healthcare's largest Q3 2018 buy was HCA Healthcare: 55,000 shares worth $7.65M.
  • Sivik Global Healthcare added most to Cigna in Q3 2018, an estimated $2.78M increase.
  • Sivik Global Healthcare's biggest Q3 2018 reduction was Cencora, cutting an estimated $3.68M.
  • Sivik Global Healthcare fully exited Zoetis in Q3 2018, selling an estimated $4.68M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $280M portfolio in Q3 2018.
  • Sivik Global Healthcare opened 13 new positions and closed 12 in Q3 2018.
  • Sivik Global Healthcare's portfolio value rose 7.7% quarter-over-quarter to $280M.

Based on Sivik Global Healthcare's 13F filing for Q3 2018, filed 13 Nov 2018.